Investing in emerging medicines is important, but it is also a complex, multidimensional decision that requires a partner who understands the journey, the passion, and the patient needs that drive innovators forward. 

As patients ourselves, we are deeply committed to helping innovative companies create pathways to commercialization for new therapeutics.